Pharmafile Logo
Pharmafocus logo
Advanced Search

ViroCell Biologics

Showing 2 posts of 2 posts found.

ViroCell Biologics and AvenCell Therapeutics partner to accelerate allogeneic CAR-T therapy development

July 29, 2025
Contract Manufacturing, Manufacturing Services, Mergers and Acquisitions, Research and Development AvenCell Therapeutics, CAR-T therapy, Contract Development Manufacturing Organisation, Good Manufacturing Practice, Immunology, Oncology, ViroCell Biologics, autoimmune diseases, blood cancer

ViroCell Biologics has announced a new manufacturing collaboration with AvenCell Therapeutics to produce a high-yield retroviral vector supporting the clinical …

News

ViroCell Biologics signs Master Services Agreement with NCI-designated cancer centre

July 23, 2024
Business Services Cancer, Oncology, ViroCell Biologics, agreement

ViroCell Biologics has announced that it has signed a five-year Master Services Agreement (MSA) with a prominent US-based NCI-designated cancer …

News
The Gateway to Local Adoption Series

Latest content

Global coalition calls for stronger government action on COPD

September 18, 2026

Global health researchers call for more equitable partnerships

September 17, 2026

Liverpool launches £20m lab for infectious disease drug discovery

September 16, 2026

Circle Health Group expands into UK laboratory operations

September 15, 2026

FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

September 14, 2026